Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2007
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007US7300930 Therapeutic acridone and acridine compounds
11/27/2007US7300928 Benzimidazolidinone derivatives as muscarinic agents
11/27/2007US7300907 2-(Poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides
11/27/2007US7300662 Local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography, lower systemic toxicity
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/27/2007CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/22/2007WO2007133491A1 Substituted spirocyclic cgrp receptor antagonists
11/22/2007WO2007133108A1 Pharmaceutical composition, method for the production and the use thereof
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132906A1 Benzylamine derivatives as cetp inhibitors
11/22/2007WO2007132307A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007WO2007132010A1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors
11/22/2007WO2007131764A2 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007WO2007131366A1 Iap bir domain binding compounds
11/22/2007WO2007117482A3 Renin inhibitors
11/22/2007WO2007105989A3 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
11/22/2007WO2007095495A3 Benzodiazepine gcnf modulators for stem cell modulation
11/22/2007WO2007075783A3 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
11/22/2007WO2007062314A3 Heterocyclic cetp inhibitors
11/22/2007WO2007044885A3 Piperidine derivatives and methods of use
11/22/2007WO2006135839A3 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor
11/22/2007WO2006099268A3 Cgrp receptor antagonists
11/22/2007WO2006049835A3 Indole and benzimidazole derivatives
11/22/2007WO2005046589A3 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
11/22/2007US20070270570 White electroluminescent polymeric material and preparation thereof
11/22/2007US20070270474 Pyrazole compounds for treatment of neurodegenerative disorders
11/22/2007US20070270471 Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine
11/22/2007US20070270466 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists
11/22/2007US20070270465 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl) piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
11/22/2007US20070270464 Prodrugs of curcumin analogs
11/22/2007US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents
11/22/2007US20070270422 Aromatic Compounds
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270419 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
11/22/2007US20070270416 Active Compound Combinations Having Insecticidal and Acaricidal Properties
11/22/2007US20070270411 Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors
11/22/2007US20070270410 N3-[4-(4-Morpholin-4-yl-cyclohexyl)-phenyl]-1-pyridin-2-yl-1H-[1,2,4]triazole-3,5-diamine; antiproliferative agent; Alzheimer's Disease; Multiple Sclerosis Parkinson's Disease, asthma, schizophrenia, anti-nflammatory agent; cardiovascular disease; bone disorders
11/22/2007US20070270407 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
11/22/2007US20070270395 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 2-Cyclopropylmethoxy-4-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
11/22/2007US20070270312 Heteroaroyl-Substituted Serineamides
11/22/2007US20070269374 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
11/22/2007US20070267970 Nitrogen-containing heterocyclic derivatives and organic electroluminescence device using the same
11/22/2007US20070267968 Electronic devices made with electron transport and/or anti-quenching layers
11/22/2007DE102007021043A1 Alpha-Form von Imatinib Mesylat und Verfahren zu seiner Herstellung Alpha-form of imatinib mesylate and a process for its preparation
11/22/2007CA2653753A1 Substituted prolinamides, production thereof and their use as medicaments
11/22/2007CA2652455A1 Iap bir domain binding compounds
11/22/2007CA2652101A1 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007CA2651629A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007CA2650515A1 Benzylamine derivatives as cetp inhibitors
11/22/2007CA2647238A1 2,4-diamino pyrimidines as cell cycle kinase inhibitors
11/21/2007EP1858094A1 Organic compound, charge transport material and organic electroluminescent device
11/21/2007EP1857455A1 Cinnamoyl compound and use thereof
11/21/2007EP1857454A1 Crystalline imatinib base and production process therefor
11/21/2007EP1857453A1 Fluoroalkylpyrrolidine derivative
11/21/2007EP1857444A1 Tetrahydroisoquinoline compound and medicinal use thereof
11/21/2007EP1857442A2 Novel antimycobacterial compounds
11/21/2007EP1857104A1 Use of cinnamoyl compound
11/21/2007EP1856112A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/21/2007EP1856110A1 Oxyindole derivatives as 5ht4 receptor agonists
11/21/2007EP1856108A1 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions
11/21/2007EP1856107A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists
11/21/2007EP1856101A2 Process for preparing amorphous salts
11/21/2007EP1856100A2 Cgrp receptor antagonists
11/21/2007EP1856099A2 Acridine and quinoline derivatives as sirtuin modulators
11/21/2007EP1856098A2 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/21/2007EP1856097A2 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/21/2007EP1856096A2 Phenylglycinamide derivatives useful as anticoagulants
11/21/2007EP1856095A1 Quinazoline derivatives as tyrosine kinase inhibitors
11/21/2007EP1856094A1 Microcrystalline (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)acetic acid
11/21/2007EP1856093A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
11/21/2007EP1856092A1 6-heteroaryl-1,2,3,4,4a,10b-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders
11/21/2007EP1856074A2 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents
11/21/2007EP1856063A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
11/21/2007EP1856059A2 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors
11/21/2007EP1856058A2 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
11/21/2007EP1856053A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
11/21/2007EP1856049A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/21/2007EP1855676A1 Tetracyclic amino and carboxamido compounds and methods of use thereof
11/21/2007EP1855670A2 Benzazole potentiators of metabotropic glutamate receptors
11/21/2007EP1855531A2 Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
11/21/2007EP1578425B1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/21/2007EP1523313B1 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4- 1-(pyridin-2-ylmethyl)piperidin-4-yl -1h-indol-3-yl -1h-pyrrole mono-hydrochloride
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1458383B1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007CN101076528A Organic compound, charge transport material and organic electroluminescent element
11/21/2007CN101076527A Tricyclic anilide spirohydantoin cgrp receptor antagonists
11/21/2007CN101074242A Cells accumulation for sphosphonate analogs of HIV protease inhibitor compound and the same compound
11/21/2007CN101074227A Phosphine acyloxy quinazoline derivatives and their medicine using
11/21/2007CN101073781A 4-dimethy-pyridine organic molecular-catalyst containing dinaphthalene chiral functional based and its production
11/21/2007CN100349890C Quinazoline(di) ones for invertebrate pest control
11/21/2007CN100349889C Substituted benzoyl derivatives as herbicides
11/21/2007CN100349888C Medicine compound
11/21/2007CN100349887C Substituted 4-aryl-4H-pyrrolo[2,3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2007CN100349874C Novel compounds
1 ... 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 ... 1080